
Duck Creek Technologies Launches Payments Facilitator to Create End-To-End Insurance Payment Solution

Recursion Announces FDA Clearance of Investigational New Drug Application for REC-1245, a Potential First-In-Class RBM39 Degrader for Biomarker-Enriched Solid Tumors and Lymphoma

Dawn Bates International Ltd (DBI) Founder and Social Justice Advocate Dawn Bates Shortlisted for Two Prestigious UK Businesswomen Awards


